News-Medical.Net on MSN
TGM2 as a novel biomarker for acute myocardial infarction and prognosis in acute coronary syndrome
Announcing a new article publication for Cardiovascular Innovations and Applications journal. Transglutaminase 2 (TGM2) has been implicated in various health conditions, yet its role in acute coronary ...
Background Cardiogenic shock (CS) complicating acute myocardial infarction (AMI) carries high mortality. Early ...
Credit: Getty Images A discussion of the use of beta-blocker therapy following AMI, with Christopher Granger, MD, Gregg Fonarow, MD, and Carlin S Long, MD. Beta blockers have long been included in the ...
Patients with elevated epicardial adipose tissue volume (EATV) exhibit greater acute myocardial injury following acute myocardial infarction (AMI), according to a study presented at the annual ...
The proof of efficacy of thrombolysis for acute myocardial infarction (AMI) depends on 9 randomized placebo-controlled trials totaling 58,511 patients. The meta-analysis of these trials showed an ...
Although the use of primary angioplasty in the acute myocardial infarction (AMI) setting has been shown to achieve TIMI 3 flow in the majority of patients, there are still some instances in which ...
Empagliflozin reduces heart failure hospitalization risk in patients with acute myocardial infarction, irrespective of type 2 diabetes or chronic kidney disease status. The EMPACT-MI trial showed a 23 ...
Announcing a new article publication for Cardiovascular Innovations and Applications journal. Cardiovascular diseases, particularly acute myocardial infarction, are the leading cause of disability and ...
Despite a previous decline, AMI mortality rates are increasing among individuals with nicotine dependence in the US. Recent increases in acute myocardial infarction (AMI) mortality rates with nicotine ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results